DeNovX is an innovative pharmaceutical company specializing in drug development, life science research, commercialization, and intellectual property. Their expertise is focused on advancing technology platforms to enhance human lives by improving crystallization outcomes for pharmaceutical discovery, development, and manufacturing. DeNovX provides platform products for pharmaceutical and medical nutrition uses, with a division dedicated to developing treatments for conditions like ulcerative colitis. Additionally, they focus on commercializing products to accelerate pharmaceutical development and create new intellectual property for relevant products.